You just read:

Libtayo® (cemiplimab-rwlc) Data at ESMO 2018 Congress Provide New Insights in Six Tumor Types Under Investigation

News provided by

Regeneron Pharmaceuticals, Inc.

Oct 08, 2018, 18:05 ET